Perspectives on the Tertiary Prevention Strategy for Alzheimer's Disease. - Wikidata - awgldk - TriplyDB

Perspectives on the Tertiary Prevention Strategy for Alzheimer's Disease.

Perspectives on the Tertiary Prevention Strategy for Alzheimer's Disease.

http://www.wikidata.org/entity/Q37204006

about

Towards Personalized Intervention for Alzheimer's Disease Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer's disease patients.The potential of solanezumab and gantenerumab to prevent Alzheimer's disease in people with inherited mutations that cause its early onset.

P2860

Q28080098-2F522371-7434-4468-893E-F24A805238DA Q38966308-E60B7F95-5275-46CC-986B-117E7ABD86E3 Q47567135-6C4EB964-8F22-48FF-9309-DB637C1C198F

P2860

Perspectives on the Tertiary Prevention Strategy for Alzheimer's Disease.

http://www.wikidata.org/entity/Q37204006

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 14 December 2015

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Perspectives on the Tertiary Prevention Strategy for Alzheimer's Disease.

@en

Perspectives on the Tertiary Prevention Strategy for Alzheimer's Disease.

@nl

type

label

Perspectives on the Tertiary Prevention Strategy for Alzheimer's Disease.

@en

Perspectives on the Tertiary Prevention Strategy for Alzheimer's Disease.

@nl

prefLabel

Perspectives on the Tertiary Prevention Strategy for Alzheimer's Disease.

@en

Perspectives on the Tertiary Prevention Strategy for Alzheimer's Disease.

@nl

P1433

Q37204006-BA8CC2EF-96E2-4F48-92ED-03CE437EBF3D

P1476

Q37204006-A6FD2974-E256-40DB-8D87-550047398362

P2093

Q37204006-17DD4AEE-0B90-411E-9885-7B249C78D7AE

Q37204006-1C0D08C1-AA18-4F9E-B68F-4D5BA54F656E

P275

Q37204006-71781AB7-7C38-4E2A-9A58-56161665B15C

P2860

Q37204006-01C92601-C215-4C68-94BC-B1DA842088F5

Q37204006-03DB1A3B-4FE4-47FC-9804-ACC2C3F796A6

Q37204006-0582BA18-CB6D-4701-8B77-55B234BF7C0A

Q37204006-07B493B3-F6EF-4C9F-9438-C35B2CACFAEC

Q37204006-099139A2-EC6B-49D9-B23D-B60FBFADC3F6

Q37204006-0B42956E-321D-478A-89DD-F59F8C137A82

Q37204006-0B9168C3-ACDF-4BF7-9201-D15DD9E3E9A7

Q37204006-0C44CB5A-BDA4-445C-83E8-3DC4A520D66E

Q37204006-105F0C76-C147-44EB-842F-767ED8F74CCD

Q37204006-15B34A5B-3982-4556-8FF7-6B64E09F1B0A

P304

Q37204006-57586F4E-890A-4E9C-A1C6-9A630548B2A7

P31

Q37204006-760F263C-1EEE-483F-9C51-83D4F6D5B9D4

P356

Q37204006-762E6581-271E-4D4D-9C1A-8F6B86DCA725

P433

Q37204006-1395A8DB-34D3-47FB-BB47-057C7A5ABBFF

P478

Q37204006-FA8888C0-B17A-4AD7-94DA-CE23F27BA3D6

P50

Q37204006-06AE4F9B-4320-46FE-B6C6-429B66102881

Q37204006-22171BDA-5FE3-481F-802B-025B40643E99

P5008

Q37204006-3B30E923-408F-45B2-BE7B-222938112EB1

P577

Q37204006-FBC3114D-2DB8-4AFE-A3C4-90406D257110

P5875

Q37204006-0ADE1F7C-F346-41AF-A75D-770707483508

P698

Q37204006-123563EF-66E7-4E56-AE5A-CD6DA9495853

P921

Q37204006-2805EA8F-C17F-4F01-8F3E-EA4F317E8900

Q37204006-E195536F-B702-4E9E-9F4C-D019357A1945

P932

Q37204006-A0B1DED2-146D-403A-ABBC-39777C3CA4F2

P356

1567205013666151215110114

P1433

Current Alzheimer Research

P1476

Perspectives on the Tertiary Prevention Strategy for Alzheimer's Disease

@en

P2093

Shu-Sheng Jiao

http://www.w3.org/2001/XMLSchema#string

Yan Lian

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline

Alzheimer mechanisms and therapeutic strategies

Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice

Protective Effects of Physical Exercise in Alzheimer's Disease and Parkinson's Disease: A Narrative Review

Link between type 2 diabetes and Alzheimer's disease: from epidemiology to mechanism and treatment

The role of inflammasome in Alzheimer's disease

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease

A meta-analysis of cytokines in Alzheimer's disease

P304

307-316

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/1567205013666151215110114

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

P5008

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

287151178

http://www.w3.org/2001/XMLSchema#string

P698

26667888

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

preventive health services

P932

4997925

http://www.w3.org/2001/XMLSchema#string